Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
111544122 | 11154412 | 2 | F | 20150507 | 20150529 | 20150602 | 20160821 | EXP | US-ROCHE-1529117 | ROCHE | 43.44 | YR | M | Y | 53.57000 | KG | 20160822 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
111544122 | 11154412 | 1 | PS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | 50723 | 500 | MG | TABLET | BID | |||||||
111544122 | 11154412 | 2 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | 2 TABLETS | 50723 | 500 | MG | TABLET | BID | ||||||
111544122 | 11154412 | 3 | C | BUMETANIDE. | BUMETANIDE | 1 | Unknown | 0 | 2 | G | |||||||||
111544122 | 11154412 | 4 | C | CARVEDILOL. | CARVEDILOL | 1 | 0 | ||||||||||||
111544122 | 11154412 | 5 | C | LANOXIN | DIGOXIN | 1 | Unknown | .125 | 0 | ||||||||||
111544122 | 11154412 | 6 | C | CAPTOPRIL. | CAPTOPRIL | 1 | Unknown | 12.5 | 0 | ||||||||||
111544122 | 11154412 | 7 | C | ASA | ASPIRIN | 1 | Unknown | 0 | 81 | MG | |||||||||
111544122 | 11154412 | 8 | C | ALDACTONE | SPIRONOLACTONE | 1 | Unknown | 0 | 25 | G | |||||||||
111544122 | 11154412 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 20 | 0 | ||||||||||
111544122 | 11154412 | 10 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Unknown | 10 | 0 | ||||||||||
111544122 | 11154412 | 11 | C | CHOLESTYRAMINE. | CHOLESTYRAMINE | 1 | Unknown | 0 | |||||||||||
111544122 | 11154412 | 12 | C | LASIX | FUROSEMIDE | 1 | Unknown | 20 | 0 | ||||||||||
111544122 | 11154412 | 13 | C | REGLAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
111544122 | 11154412 | 14 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | Unknown | 25 | 0 | ||||||||||
111544122 | 11154412 | 15 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | 25 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
111544122 | 11154412 | 1 | Systemic scleroderma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
111544122 | 11154412 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
111544122 | 11154412 | Death | |
111544122 | 11154412 | Off label use | |
111544122 | 11154412 | Patient-device incompatibility | |
111544122 | 11154412 | Scleroderma | |
111544122 | 11154412 | Skin tightness | |
111544122 | 11154412 | Tympanic membrane disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |